Tenderwize
Back to tender search

Non-exclusive discount agreement for Tamsulosin and Dutasterid

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 226 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tamsulosin und Dutasterid, ATC G04CA52

55/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

55 / 100

Complexity

40 / 100

Risk factors

Non-exclusive contracts may be terminated early if the buyer initiates exclusive tenders; no guaranteed revenue.

Paper submission increases risk of delays or loss; must meet strict receipt deadlines.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount agreements for pharmaceuticals with active substance Tamsulosin and Dutasterid (ATC G04CA52)
  • Exclusion of paediatric medicines according to BfArM list per §35 Abs. 5a SGB V
Show full summary

The tender is an open-house non-exclusive discount agreement for pharmaceutical products containing Tamsulosin and Dutasterid (ATC G04CA52), offered by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse. All eligible pharmaceutical companies can join on equal terms. Contracts run for a maximum of 24 months, with the earliest start on 01.06.2025 and latest end on 31.05.2027. Enrollment is possible monthly, subject to a two-month lead time. The notice explicitly states it is not a public procurement under EU directives but is published for transparency. No estimated value is provided.

Risks

Non-exclusive contracts may be terminated early if the buyer initiates exclusive tenders; no guaranteed revenue.

Paper submission increases risk of delays or loss; must meet strict receipt deadlines.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Pharmaceutical companies must hold a valid marketing authorization for the relevant products in Germany
  • Products must be listed as marketable in the Lauer-Taxe or provide evidence via AMIce database extracts

Administrative

  • Submission of signed contract documents by the appropriate deadline (first deadline 30.04.2025 for start 01.06.2025; subsequent deadlines are 2 months before intended start date)

Requirements may be incomplete.

Award Criteria

Lot 1

No explicit award criteria; all participants are accepted under uniform terms (open-house).

Buyer

Lots (1)

LOT-0001

Non-exclusive discount agreement for Tamsulosin and Dutasterid

Open-house model for non-exclusive discount agreements on pharmaceuticals with active substances Tamsulosin and Dutasterid. All qualified pharmaceutical companies can participate. Terms are uniform; no individual negotiations. Contracts end automatically if exclusive agreements replace them.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Award Criteria

No explicit award criteria; all participants are accepted under uniform terms (open-house).

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
236184-2025

Documents (1)

Similar tenders